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apy titer decreases (treatment success) occurred in 87.9%
of Bartonella-infected cats. 78 of 88 (88.6%) Bartonella-
seropositive dogs had post therapy titer decreases (2 fold
n = 8, 4 fold or greater n = 70) as did all 3 people with CSD (4
fold or greater).
Conclusion: Antibiotic therapy of Bartonella-seropositive
cats, dogs, and people can be effectively monitored using a
comparative WB titration test.
doi:10.1016/j.ijid.2008.05.1318
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Culture and biochemical assay remain as ‘‘gold stan-
dard’’ for identiﬁcation and conﬁrmation of B. pseudoma-
llei. However conﬁrmation by API 20NE biochemical assay
is time consuming as the identiﬁcation can only be done
24 hours onwards up to a week. Consequently, treatment of
the patients suspected for melioidosis can be delayed and
increases mortality rate as death can occur within 24 hours
onset of the disease. Therefore there is a need to develop an
assay that can shorten the time for identiﬁcation and con-
ﬁrmation of B. pseudomallei from cultures. In this study, a
rapid slide agglutination assay was developed using a speciﬁc
monoclonal antibody raised against culture ﬁltrate antigen
of B. pseudomallei in Balb-C mice. The puriﬁed monoclonal
antibody was tagged onto 0.8 um latex particles by means of
passive adsorption. Latex agglutination assay was performed
on a total of 45 B. pseudomallei strains and additional of ﬁve
other Burkholderia species on glass microscope slide. Cross
reactivity studies were performed on control panel strains
which consisted of various gram-negative and gram-positive
organisms. The latex agglutination assay was able to identify
correctly 44 of 45 B. pseudomallei strains with a remarkable
sensitivity of 97.8% and speciﬁcity of 100%. No cross reac-
tion was observed with the control panel strains. In addition,
latex agglutination assay was also performed on various B.
pseudomallei antigen and compared with the developed
assay. It was found that the developed latex agglutination
assay is useful in identiﬁcation and conﬁrmation of B. pseu-
domallei from cultures.
doi:10.1016/j.ijid.2008.05.1319
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Background: To compare the results of Direct Fluorescent
antigen detection (DFA) with the routine direct examina-
tion as Giemsa stain, Toluidine blue O stain and Ammoniacal
silver stain for detecting Pneumocystis jiroveci pneumonia
(PCP) in bronchoalveolar lavage spacimens (BAL) taken from
symptomatic HIV seropositive patients.
Methods: Bronchoalveolar lavage specimens were exam-
ined from 57 symptomatic HIV seropositive patients sending
to National institute of Health, Thailand. Specimens were
examined for PCP using routine direct examination as
Giemsa stain, Toluidine blue O stain and Ammoniacal silver
stain and by Direct Fluorescent antigen detection (DFA)
Results: Of the 57 specimens analysed were 24 posi-
tive by DFA. An addition two specimens were routine direct
examination negative and DFA positive. Compared to rou-
tine direct examination, the sensitivity and speciﬁcity of the
DFA assay for the detection of P. jiroveci from BAL specimens
sensitivity, speciﬁcity of were 100 and 94.3%. By the way pos-
itive predictive value (PPV), negative predictive value (NPV)
and efﬁciency were 91.7 and 100 and 96.5%, respectively
Conclusions: this study has shown that DFA assay for the
detection of P. jioveci has a high sensitivity and speciﬁcity
and can be adapted for use in the clinical microbiology lab-
oratory reqire ﬂuorescent microscopy.
doi:10.1016/j.ijid.2008.05.1320
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Background: Current PCR and qPCR methods used in
detecting and/or quantifying pathogenic agents present in
patient sample have become the essential application for
most diagnostic laboratories. Despite these methods have
high sensitivity, technical issues are currently the most inﬂu-
encing factors for the quality of these present in-house
methods. Therefore, development of a good quality control
protocol has now become the vital next step.
Objectives: To develop and to construct the internal
control using the same primers of the target in order to stan-
dardize the quality of PCR and qPCR results used in pathogen
diagnosis.
Methods: Based on the molecular biotechnology, we
designed and developed the internal controls which can be
used with the same primers as for the target. After that,
the LOD (limit of detection) concentration that can give
detectable signal without inhibiting ampliﬁcation of the tar-
get, were determined for these internal controls. These
LOD determinations are very essential since the input of
the internal control at the LOD to the samples and to the
negative control sample can control the sensitivity of the
nucleic extraction, the ampliﬁcation; can detect the con-
tamination as well as the inhibition without the need of
multiple controls as usual
Results: Using the mentioned methods, various designed
internal controls have been designed and constructed for
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PCR and qPCR detection of HCV, HBV, Dengue, HIV, HSV, H5,
CMV, M. tuberculosis, C. trachomatis and N. gonorrhoeae.
This method has been being employed for all PCR diagnostic
tests carried out at our laboratory, as well as at other diag-
nostic laboratories where our PCR diagnostic kits are being
used.
Conclusion: This method has a broad application poten-
tial since it can be used in diagnostic laboratories which are
capable of doing PCR to detect human pathogens. Addition-
ally, it can be helpful for developing the standard criteria
for diagnostic PCR.
doi:10.1016/j.ijid.2008.05.1321
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Background: Systemic inﬂammatory response syndrome
(SIRS), severe infection and sepsis are the problems of
present interest in contemporary neonatal medicine. The
speciﬁcity and sensitivity of widespread clinical and lab-
oratory parameters are insufﬁcient for diagnosing these
diseases. A new marker for diagnosing of infective eti-
ology of SIRS, severe infection and sepsis which allows
early diagnosis and begin speciﬁc treatment is procal-
citonin (ProCT). We perfomed our study to evaluate
the speciﬁcity of ProCT as marker of neonatal infec-
tion and we have determined serum ProCT concentration
in conditions associated to inﬂammatory response: Sep-
sis, Asphyxia, RDS, Localized Infection and in uninfected
patients.
Methods: The study includes 131 newborns admitted to
the Neonatal Intensive Care Unit and divided in 5 groups:
Sepsis, Asphyxia, RDS, Localized Infection and in uninfected
patients. ProCT was determined by Biochemistry Laboratory
using an immunoluminometric assay, Lumi test, monoclonal
antibodies on speciﬁc region of ProCT
Results: Serum ProCT value correlates with the sever-
ity of Sepsis: the more severe the Sepsis, the higher the
level of ProCT (p < 0.002). Serum ProCT values were highly
variable in other groups. In RDS and Asphyxia groups the
serum ProCT levels does not elevate or increases mod-
erately. Comparison between groups showed a statistical
signiﬁcant Sepsis vs Asphyxia, Localized Infection, RDS
(p < 0.0001).
Conclusion: At birth newborns adaptations and metabolic
changes inﬂuence haematologic index. Sensitive tests are of
great utility in NICU where patients present a wide variety
of neonatal and perinatal disorders with laboratory values
similar to those caused by infections. Our study showed
that ProCt value was signiﬁcantly higher in infected than
in non infected newborns (p < 0.002). ProCT is considered as
a marker of severe bacterial and viral infection. However,
in neonatal period, the monitoring of PCT allows a rapid
diagnosis of infection and is most valuable for evaluating
treatment effeciency and prognosis.
doi:10.1016/j.ijid.2008.05.1311
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Nucleic acid assays based on PCR ampliﬁcation employ
agarose gel electrophoresis and ethidium bromide staining
for detection. Ethidium bromide is harmful and elec-
trophoresis requires at least one hour to perform. Though
real-time PCR allows continuous monitoring of the PCR
product by ﬂuorometric hybridisation, it requires highly spe-
cialized, expensive equipment along with costly reagents.
In this work, we report a simple dry-reagent disposable
biosensor for the visual detection of ampliﬁed PCR prod-
uct. The bacterial model system used to develop this
assay was Enterococcus faecium. A pair of primers modi-
ﬁed at the 5′end with either hapten (biotin or ﬂuorescein)
was designed to amplify a speciﬁc region of the 16S RNA
of E. faecium. The ampliﬁed hapten-labelled DNA was
directly applied to a membrane immobilized with dry form
of streptavidin-coated microsphere test line (T) and anti-
mouse IgG antibody-coated microsphere control line (C).
The streptavidin captured the biotinylated PCR product
while visual signal was generated by using anti-ﬂuorescein
conjugated gold nanoparticles. The ﬁnal result was read in
3—5minutes. One single (C) line in the membrane indicated
the absence of E. faecium; two lines of both (T) and (C) indi-
cated the presence of E. faecium. Occurrence of a line in
(C) indicated that the test worked properly. The analytical
sensitivity of the biosensor was found to be 104 CFU/ml and
13 ng at DNA level. The analytical sensitivity was one log
lower than that detectable by agarose gel electrophoresis.
The assay showed 100% and 95.65% sensitivity and speci-
ﬁcity respectively when tested with 9 E. faecium strains
and 23 non-E. faecium strains. Thus this disposable dry-
reagent biosensor (a) offers a cheap alternative for rapid
visualization of ampliﬁed DNA; (b) eliminates the multiple
incubation and washing steps in current hybridization assays
(c) is cost-effective and environmental friendly.
doi:10.1016/j.ijid.2008.05.1312
